Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447317 · ClinicalTrials.gov registry record · NA
Dietary Adherence Enhancement in Peritoneal Dialysis: BalanceWise-PD
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00447317 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 60 participants.
The verdict
NCT00447317, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This randomized study will pilot test an intervention, based on self-efficacy theory and involving personal digital assistant (PDA)-based dietary self-monitoring, to improve adherence to the peritoneal dialysis dietary regimen. 60 individuals, 21 years of age or older, who are on continuous ambulatory peritoneal dialysis or nightly cycler peritoneal dialysis, will be recruited to the study. Participants will be randomized to one of 2 groups. Group A will receive a 4-month active intervention of decreasing intensity over time delivered via mail, telephone, and during regularly scheduled dialysis clinic visits. Group B will receive a 4-month attention control experience in which they receive reinforcement of standard dietary education. With this study the investigators will: 1. Explore the impact of the intervention on dietary sodium intake, 2. Explore the intervention on blood pressure, 3. Explore the impact of the intervention on morning post dialysis weight (i.e. weight after conclusion of continuous cycling peritoneal dialysis (CCPD) or after long dwell for continuous ambulatory peritoneal dialysis (CAPD) patients, AND 4. Explore the feasibility and acceptability of the intervention
Interventions
- BEHAVIORAL Attention control
- BEHAVIORAL BalanceWise-PD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-11 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00447317
The ClinicalTrials.gov registry entry for NCT00447317 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention control is the first listed.
NCT00447317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00447317 about?
NCT00447317 is a clinical study titled "Dietary Adherence Enhancement in Peritoneal Dialysis: BalanceWise-PD". This randomized study will pilot test an intervention, based on self-efficacy theory and involving personal digital assistant (PDA)-based dietary self-monitoring, to improve adherence to the peritoneal dialysis dietary regimen. 60 individuals, 21 years of age or older, who are on continuous ambulato...
What is the current status of trial NCT00447317?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2007-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00447317?
The interventions under investigation include: Attention control (BEHAVIORAL), BalanceWise-PD (BEHAVIORAL).
Who is sponsoring clinical trial NCT00447317?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.